{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:13:39Z","timestamp":1790806419422,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2702001"],"award-info":[{"award-number":["2021YFC2702001"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018609","name":"High-level Hospital Construction Project of Guangdong Provincial People's Hospital","doi-asserted-by":"publisher","award":["National High Level Hospital Clinical Research Funding"],"award-info":[{"award-number":["National High Level Hospital Clinical Research Funding"]}],"id":[{"id":"10.13039\/501100018609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2019-I2M-5-002"],"award-info":[{"award-number":["2019-I2M-5-002"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2024-12M-C&T-B-018"],"award-info":[{"award-number":["2024-12M-C&T-B-018"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12519-026-01035-4","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:54:11Z","timestamp":1782230051000},"page":"613-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beh\u00e7et\u2019s spectrum disorders: genetic and immunological insights into an emerging disease concept"],"prefix":"10.1007","volume":"22","author":[{"given":"Hui-Nan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Hao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9801-2517","authenticated-orcid":false,"given":"Hong-Mei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"publisher","first-page":"14405","DOI":"10.1073\/pnas.2002051117","volume":"117","author":"K Manthiram","year":"2020","unstructured":"Manthiram K, Preite S, Dedeoglu F, Demir S, Ozen S, Edwards KM, et al. Common genetic susceptibility loci link PFAPA syndrome, Beh\u00e7et\u2019s disease, and recurrent aphthous stomatitis. Proc Natl Acad Sci USA. 2020;117:14405\u201311. https:\/\/doi.org\/10.1073\/pnas.2002051117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1035_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60040562","volume":"60","author":"S Lavalle","year":"2024","unstructured":"Lavalle S, Caruso S, Foti R, Gagliano C, Cocuzza S, La Via L, et al. Beh\u00e7et\u2019s disease, pathogenesis, clinical features, and treatment approaches: a comprehensive review. Medicina B Aires. 2024;60:562. https:\/\/doi.org\/10.3390\/medicina60040562.","journal-title":"Medicina B Aires"},{"key":"1035_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109661","volume":"253","author":"AF Al-Obeidi","year":"2023","unstructured":"Al-Obeidi AF, Nowatzky J. Immunopathogenesis of Beh\u00e7et\u2019s disease. Clin Immunol Orlando Fla. 2023;253:109661. https:\/\/doi.org\/10.1016\/j.clim.2023.109661.","journal-title":"Clin Immunol Orlando Fla"},{"key":"1035_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100056","volume":"3","author":"A Mendes-Frias","year":"2020","unstructured":"Mendes-Frias A, Santos-Lima B, Furtado DZS, Ruperez FJ, Assun\u00e7\u00e3o NA, Matias MJ, et al. Dysregulation of glycerophospholipid metabolism during Beh\u00e7et\u2019s disease contributes to a pro-inflammatory phenotype of circulating monocytes. J Transl Autoimmun. 2020;3:100056. https:\/\/doi.org\/10.1016\/j.jtauto.2020.100056.","journal-title":"J Transl Autoimmun"},{"key":"1035_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-016-0130-7","volume":"13","author":"M-Y Woo","year":"2016","unstructured":"Woo M-Y, Yun SJ, Cho O, Kim K, Lee E-S, Park S. MicroRNAs differentially expressed in Beh\u00e7et disease are involved in interleukin-6 production. J Inflamm Lond. 2016;13:22. https:\/\/doi.org\/10.1186\/s12950-016-0130-7.","journal-title":"J Inflamm Lond"},{"key":"1035_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","volume":"48","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48:67\u201373. https:\/\/doi.org\/10.1038\/ng.3459.","journal-title":"Nat Genet"},{"key":"1035_CR7","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3760\/cma.j.issn.0578-1310.2019.12.006","volume":"57","author":"LQ Zhong","year":"2019","unstructured":"Zhong LQ, Wang W, Wang L, Jiang JJ, Shen M, Song HM. A report of clinical characteristics of 2 Chinese pedigrees with haploinsufficiency of A20 and literature review. Zhonghua Er Ke Za Zhi Chin J Pediatr. 2019;57:922\u20137. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2019.12.006.","journal-title":"Zhonghua Er Ke Za Zhi Chin J Pediatr"},{"key":"1035_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.780689","volume":"12","author":"T Kadowaki","year":"2021","unstructured":"Kadowaki T, Kadowaki S, Ohnishi H. A20 haploinsufficiency in East Asia. Front Immunol. 2021;12:780689. https:\/\/doi.org\/10.3389\/fimmu.2021.780689.","journal-title":"Front Immunol"},{"key":"1035_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12973","volume":"92","author":"SF Perazzio","year":"2020","unstructured":"Perazzio SF, Allenspach EJ, Eklund KK, Varjosalo M, Shinohara MM, Torgerson TR, et al. Beh\u00e7et disease (BD) and BD-like clinical phenotypes: NF-\u03baB pathway in mucosal ulcerating diseases. Scand J Immunol. 2020;92:e12973. https:\/\/doi.org\/10.1111\/sji.12973.","journal-title":"Scand J Immunol"},{"key":"1035_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/annrheumdis-2019-215918","volume":"79","author":"DM Schwartz","year":"2020","unstructured":"Schwartz DM, Blackstone S, Moura NS, Rosenzweig S, Burma A, Stone DL, et al. A type I interferon signature predicts response to JAK inhibition in haploinsufficiency of A20. Ann Rheum Dis. 2020;79:429\u201331. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215918.","journal-title":"Ann Rheum Dis"},{"key":"1035_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.autrev.2018.02.012","volume":"17","author":"F Berteau","year":"2018","unstructured":"Berteau F, Rouviere B, Delluc A, Nau A, Le Berre R, Sarrabay G, et al. Autosomic dominant familial Beh\u00e7et disease and haploinsufficiency A20: a review of the literature. Autoimmun Rev. 2018;17:809\u201315. https:\/\/doi.org\/10.1016\/j.autrev.2018.02.012.","journal-title":"Autoimmun Rev"},{"key":"1035_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13075-019-1928-5","volume":"21","author":"N Tsuchida","year":"2019","unstructured":"Tsuchida N, Kirino Y, Soejima Y, Onodera M, Arai K, Tamura E, et al. Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Beh\u00e7et\u2019s disease. Arthritis Res Ther. 2019;21:137. https:\/\/doi.org\/10.1186\/s13075-019-1928-5.","journal-title":"Arthritis Res Ther"},{"key":"1035_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41590-021-00984-4","volume":"22","author":"PM Tyler","year":"2021","unstructured":"Tyler PM, Bucklin ML, Zhao M, Maher TJ, Rice AJ, Ji W, et al. Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation. Nat Immunol. 2021;22:1118\u201326. https:\/\/doi.org\/10.1038\/s41590-021-00984-4.","journal-title":"Nat Immunol"},{"key":"1035_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01610-8","volume":"44","author":"SJ Olyha","year":"2024","unstructured":"Olyha SJ, O\u2019Connor SK, Kribis M, Bucklin ML, Uthaya Kumar DB, Tyler PM, et al. \u201cDeficiency in ELF4, x-linked\u201d: a monogenic disease entity resembling Beh\u00e7et\u2019s syndrome and inflammatory bowel disease. J Clin Immunol. 2024;44:44. https:\/\/doi.org\/10.1007\/s10875-023-01610-8.","journal-title":"J Clin Immunol"},{"key":"1035_CR15","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42:1473\u2013507. https:\/\/doi.org\/10.1007\/s10875-022-01289-3.","journal-title":"J Clin Immunol"},{"key":"1035_CR16","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s10875-022-01243-3","volume":"42","author":"G Sun","year":"2022","unstructured":"Sun G, Qiu L, Yu L, An Y, Ding Y, Zhou L, et al. Loss of function mutation in ELF4 causes autoinflammatory and immunodeficiency disease in human. J Clin Immunol. 2022;42:798\u2013810. https:\/\/doi.org\/10.1007\/s10875-022-01243-3.","journal-title":"J Clin Immunol"},{"key":"1035_CR17","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10875-023-01453-3","volume":"43","author":"G Sun","year":"2023","unstructured":"Sun G, Wu M, Lv Q, Yang X, Wu J, Tang W, et al. A multicenter cohort study of immune dysregulation disorders caused by ELF4 variants in China. J Clin Immunol. 2023;43:933\u20139. https:\/\/doi.org\/10.1007\/s10875-023-01453-3.","journal-title":"J Clin Immunol"},{"key":"1035_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3760\/cma.j.cn112140-20240425-00289","volume":"62","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Wang LL, Zhang CY, Ding J, Ma MS, Song HM. [Two cases of deficiency in ELF4 gene x-linked and literature review]. Zhonghua Er Ke Za Zhi Chin J Pediatr. 2024;62:1164\u20138. https:\/\/doi.org\/10.3760\/cma.j.cn112140-20240425-00289.","journal-title":"Zhonghua Er Ke Za Zhi Chin J Pediatr"},{"key":"1035_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s1074-7613(02)00422-3","volume":"17","author":"HD Lacorazza","year":"2002","unstructured":"Lacorazza HD, Miyazaki Y, Di Cristofano A, Deblasio A, Hedvat C, Zhang J, et al. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity. 2002;17:437\u201349. https:\/\/doi.org\/10.1016\/s1074-7613(02)00422-3.","journal-title":"Immunity"},{"key":"1035_CR20","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","volume":"360","author":"I Aksentijevich","year":"2009","unstructured":"Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009;360:2426\u201337. https:\/\/doi.org\/10.1056\/NEJMoa0807865.","journal-title":"N Engl J Med"},{"key":"1035_CR21","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/ni.2756","volume":"14","author":"F You","year":"2013","unstructured":"You F, Wang P, Yang L, Yang G, Zhao YO, Qian F, et al. ELF4 is critical for induction of type I interferon and the host antiviral response. Nat Immunol. 2013;14:1237\u201346. https:\/\/doi.org\/10.1038\/ni.2756.","journal-title":"Nat Immunol"},{"key":"1035_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aau4604","volume":"12","author":"L Cao","year":"2019","unstructured":"Cao L, Yang G, Gao S, Jing C, Montgomery RR, Yin Y, et al. HIPK2 is necessary for type I interferon-mediated antiviral immunity. Sci Signal. 2019;12:eaau4604. https:\/\/doi.org\/10.1126\/scisignal.aau4604.","journal-title":"Sci Signal"},{"key":"1035_CR23","doi-asserted-by":"publisher","unstructured":"An JW, Pimpale-Chavan P, Stone DL, Bandeira M, Dedeoglu F, Lo J, et al. Case report: Novel variants in RELA associated with familial Behcet\u2019s-like disease. Front Immunol 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1127085.","DOI":"10.3389\/fimmu.2023.1127085"},{"key":"1035_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/art.41531","author":"JW An","year":"2021","unstructured":"Adeeb F, Dorris ER, Morgan NE, Lawless D, Maqsood A, Ng WL, et al. A novel RELA truncating mutation in a familial Beh\u00e7et\u2019s disease-like mucocutaneous ulcerative condition. Arthritis Rheumatol 2021;73:490\u20137. https:\/\/doi.org\/10.1002\/art.4153.","journal-title":"Arthritis Rheumatol"},{"key":"1035_CR25","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1084\/jem.20160724","volume":"214","author":"YR Badran","year":"2017","unstructured":"Badran YR, Dedeoglu F, Leyva Castillo JM, Bainter W, Ohsumi TK, Bousvaros A, et al. Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. J Exp Med. 2017;214:1937\u201347. https:\/\/doi.org\/10.1084\/jem.20160724.","journal-title":"J Exp Med"},{"key":"1035_CR26","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaci.2016.10.054","volume":"140","author":"M Kaustio","year":"2017","unstructured":"Kaustio M, Haapaniemi E, G\u00f6\u00f6s H, Hautala T, Park G, Syrj\u00e4nen J, et al. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J Allergy Clin Immunol. 2017;140:782\u201396. https:\/\/doi.org\/10.1016\/j.jaci.2016.10.054.","journal-title":"J Allergy Clin Immunol"},{"key":"1035_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1182\/blood.V126.23.206.206","volume":"126","author":"EM Haapaniemi","year":"2015","unstructured":"Haapaniemi EM, Kaustio M, Nurkkala H, Helminen M, Mustjoki S, Elisabet E, et al. Dominant NFKB1 mutations cause antibody deficiency and autoinflammatory episodes. Blood. 2015;126:206. https:\/\/doi.org\/10.1182\/blood.V126.23.206.206.","journal-title":"Blood"},{"key":"1035_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/sji.12251","volume":"81","author":"G Yenmis","year":"2015","unstructured":"Yenmis G, Oner T, Cam C, Koc A, Kucuk OS, Yakicier MC, et al. Association of NFKB1 and NFKBIA polymorphisms in relation to susceptibility of Beh\u00e7et\u2019s disease. Scand J Immunol. 2015;81:81\u20136. https:\/\/doi.org\/10.1111\/sji.12251.","journal-title":"Scand J Immunol"},{"key":"1035_CR29","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jaci.2019.11.051","volume":"146","author":"T Lorenzini","year":"2020","unstructured":"Lorenzini T, Fliegauf M, Klammer N, Frede N, Proietti M, Bulashevska A, et al. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin Immunol. 2020;146:901\u201311. https:\/\/doi.org\/10.1016\/j.jaci.2019.11.051.","journal-title":"J Allergy Clin Immunol"},{"key":"1035_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820139.2024.2410743","volume":"54","author":"M Zhu","year":"2025","unstructured":"Zhu M, Mao X, Huang X, Gan M, Zhang K, Chen Y. Novel serum markers that distinguish Behcet\u2019s disease from idiopathic recurrent aphthous stomatitis. Immunol Invest. 2025;54:1\u201317. https:\/\/doi.org\/10.1080\/08820139.2024.2410743.","journal-title":"Immunol Invest"},{"key":"1035_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","volume":"50","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Dinarello CA, Molgora M, Garlanda C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity. 2019;50:778\u201395. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.012.","journal-title":"Immunity"},{"key":"1035_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/sj.gene.6363882","volume":"3","author":"MR Bazrafshani","year":"2002","unstructured":"Bazrafshani MR, Hajeer AH, Ollier WER, Thornhill MH. IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS). Genes Immun. 2002;3:302\u20135. https:\/\/doi.org\/10.1038\/sj.gene.6363882.","journal-title":"Genes Immun"},{"key":"1035_CR33","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.sdentj.2021.07.007","volume":"33","author":"SJS Shabana","year":"2021","unstructured":"Shabana SJS, Mutawakkil MHZ, El-Ashmaoui HMA, Zahran FMA-Q. Interleukin-6 gene polymorphism in Saudi population with recurrent aphthous stomatitis. Saudi Dent J. 2021;33:972\u20138. https:\/\/doi.org\/10.1016\/j.sdentj.2021.07.007.","journal-title":"Saudi Dent J"},{"key":"1035_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/jop.12095","volume":"43","author":"A Al-Samadi","year":"2014","unstructured":"Al-Samadi A, Kouri V-P, Salem A, Ainola M, Kaivosoja E, Barreto G, et al. IL-17C and its receptor IL-17RA\/IL-17RE identify human oral epithelial cell as an inflammatory cell in recurrent aphthous ulcer. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2014;43:117\u201324. https:\/\/doi.org\/10.1111\/jop.12095.","journal-title":"J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"key":"1035_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08923-6","volume":"10","author":"T Dudding","year":"2019","unstructured":"Dudding T, Haworth S, Lind PA, Sathirapongsasuti JF, 23andMe Research Team, Tung JY, et al. Genome wide analysis for mouth ulcers identifies associations at immune regulatory loci. Nat Commun. 2019;10:1052. https:\/\/doi.org\/10.1038\/s41467-019-08923-6.","journal-title":"Nat Commun"},{"key":"1035_CR36","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.624","volume":"42","author":"N Mizuki","year":"2010","unstructured":"Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u00e7et\u2019s disease susceptibility loci. Nat Genet. 2010;42:703\u20136. https:\/\/doi.org\/10.1038\/ng.624.","journal-title":"Nat Genet"},{"key":"1035_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.archoralbio.2018.05.011","volume":"93","author":"D Wu","year":"2018","unstructured":"Wu D, Xin J, Liu J, Zhou P. The association between interleukin polymorphism and recurrent aphthous stomatitis: a meta-analysis. Arch Oral Biol. 2018;93:3\u201311. https:\/\/doi.org\/10.1016\/j.archoralbio.2018.05.011.","journal-title":"Arch Oral Biol"},{"key":"1035_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155864","volume":"153","author":"H Yousefi","year":"2022","unstructured":"Yousefi H, Gholami M, Zoughi M, Rezaei N, Chuppani A, Nikfar S, et al. Role of genetic polymorphisms in recurrent aphthous stomatitis: a systematic review and meta-analysis. Cytokine. 2022;153:155864. https:\/\/doi.org\/10.1016\/j.cyto.2022.155864.","journal-title":"Cytokine"},{"key":"1035_CR39","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/jop.12594","volume":"46","author":"L Izakovicova Holla","year":"2017","unstructured":"Izakovicova Holla L, Valova S, Borilova Linhartova P, Bartova J, Petanova J, Kuklinek P, et al. Association study of interleukin-1 family, interleukin-6, and its receptor gene polymorphisms in patients with recurrent aphthous stomatitis. J Oral Pathol Med. 2017;46:1030\u20135. https:\/\/doi.org\/10.1111\/jop.12594.","journal-title":"J Oral Pathol Med"},{"key":"1035_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/odi.12190","volume":"20","author":"JA Karasneh","year":"2014","unstructured":"Karasneh JA, Bani-Hani ME, Alkhateeb AM, Hassan AF, Thornhill MH. Association of MMP but not TIMP-1 gene polymorphisms with recurrent aphthous stomatitis. Oral Dis. 2014;20:693\u20139. https:\/\/doi.org\/10.1111\/odi.12190.","journal-title":"Oral Dis"},{"key":"1035_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.wjorl.2021.05.004","volume":"7","author":"A Wang","year":"2021","unstructured":"Wang A, Manthiram K, Dedeoglu F, Licameli GR. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a review. World J Otorhinolaryngol - Head Neck Surg. 2021;7:166\u201373. https:\/\/doi.org\/10.1016\/j.wjorl.2021.05.004.","journal-title":"World J Otorhinolaryngol - Head Neck Surg"},{"key":"1035_CR42","doi-asserted-by":"publisher","first-page":"7148","DOI":"10.1073\/pnas.1103681108","volume":"108","author":"S Stojanov","year":"2011","unstructured":"Stojanov S, Lapidus S, Chitkara P, Feder H, Salazar JC, Fleisher TA, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci USA. 2011;108:7148\u201353. https:\/\/doi.org\/10.1073\/pnas.1103681108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1035_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030285","volume":"8","author":"MR von Essen","year":"2019","unstructured":"von Essen MR, S\u00f8ndergaard HB, Petersen ERS, Sellebjerg F. IL-6, IL-12, and IL-23 STAT-pathway genetic risk and responsiveness of lymphocytes in patients with Multiple Sclerosis. Cells. 2019;8:285. https:\/\/doi.org\/10.3390\/cells8030285.","journal-title":"Cells"},{"key":"1035_CR44","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.1007\/s11033-022-07352-x","volume":"49","author":"D Purrahman","year":"2022","unstructured":"Purrahman D, Poniatowski \u0141A, Wojdasiewicz P, Fathi M-R, Yousefi H, Lak E, et al. The role of inflammatory mediators in the pathogenesis of periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome. Mol Biol Rep. 2022;49:8061\u20139. https:\/\/doi.org\/10.1007\/s11033-022-07352-x.","journal-title":"Mol Biol Rep"},{"key":"1035_CR45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/BOR.0000000000000956","volume":"35","author":"K Manthiram","year":"2023","unstructured":"Manthiram K. What is PFAPA syndrome? Genetic clues about the pathogenesis. Curr Opin Rheumatol. 2023;35:423\u20138. https:\/\/doi.org\/10.1097\/BOR.0000000000000956.","journal-title":"Curr Opin Rheumatol"},{"key":"1035_CR46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Y Kirino","year":"2013","unstructured":"Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, et al. Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et\u2019s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45:202\u20137. https:\/\/doi.org\/10.1038\/ng.2520.","journal-title":"Nat Genet"},{"key":"1035_CR47","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et\u2019s disease. Nat Genet. 2010;42:698\u2013702. https:\/\/doi.org\/10.1038\/ng.625.","journal-title":"Nat Genet"},{"key":"1035_CR48","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ng.3786","volume":"49","author":"M Takeuchi","year":"2017","unstructured":"Takeuchi M, Mizuki N, Meguro A, Ombrello MJ, Kirino Y, Satorius C, et al. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Beh\u00e7et\u2019s disease susceptibility. Nat Genet. 2017;49:438\u201343. https:\/\/doi.org\/10.1038\/ng.3786.","journal-title":"Nat Genet"},{"key":"1035_CR49","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00431-020-03840-z","volume":"180","author":"M Yildiz","year":"2021","unstructured":"Yildiz M, Adrovic A, Ulkersoy I, Gucuyener N, Koker O, Sahin S, et al. The role of Mediterranean fever gene variants in patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. Eur J Pediatr. 2021;180:1051\u20138. https:\/\/doi.org\/10.1007\/s00431-020-03840-z.","journal-title":"Eur J Pediatr"},{"key":"1035_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70231","volume":"28","author":"H Oka","year":"2025","unstructured":"Oka H, Sumitomo S, Yamashita D, Ohmura K. Case report: successful remission with Upadacitinib in Beh\u00e7et\u2019s syndrome following a history of PFAPA syndrome. Int J Rheum Dis. 2025;28:e70231. https:\/\/doi.org\/10.1111\/1756-185X.70231.","journal-title":"Int J Rheum Dis"},{"key":"1035_CR51","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1307361.","journal-title":"N Engl J Med"},{"key":"1035_CR52","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"PN Elkan","year":"2014","unstructured":"Elkan PN, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370:921\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1307362.","journal-title":"N Engl J Med"},{"key":"1035_CR53","first-page":"142","volume":"37","author":"GTJ van Well","year":"2019","unstructured":"van Well GTJ, Kant B, van Nistelrooij A, Ekmekci SS, Henriet SSV, Hoppenreijs E, et al. Phenotypic variability including Behcet\u2019s disease-like manifestations in DADA2 patients due to a homozygous c.973\u20132A > G splice site mutation. Clin Exp Rheumatol. 2019;37:142\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"1035_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10875-025-01876-0","volume":"45","author":"A Almojali","year":"2025","unstructured":"Almojali A, Alrasheed A, Alharbi B, Alharbi R, Alsuwairi W, Alroqi F, et al. Deficiency of adenosine deaminase 2 masquerading as Beh\u00e7et\u2019s disease: phenotypic mimicry with HLA-B*51 positivity. J Clin Immunol. 2025;45:83. https:\/\/doi.org\/10.1007\/s10875-025-01876-0.","journal-title":"J Clin Immunol"},{"key":"1035_CR55","first-page":"69","volume":"14","author":"J de Grouchy","year":"1971","unstructured":"de Grouchy J, Turleau C, L\u00e9onard C. [Study by fluorescence of a trisomy C mosaic, probably 8: 46,XY-47,XY,?8+]. Ann Genet. 1971;14:69\u201372.","journal-title":"Ann Genet"},{"key":"1035_CR56","first-page":"1100","volume":"40","author":"R Nawata","year":"1999","unstructured":"Nawata R, Shinohara K, Takahashi T, Yamada T, Katsuki K. [Refractory anemia with trisomy-8 complicated by Beh\u00e7et\u2019s disease with elevated levels of inflammatory cytokines]. Rinsho Ketsueki. 1999;40:1100\u20134.","journal-title":"Rinsho Ketsueki"},{"key":"1035_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3969\/j.issn.1672-8467.2021.04.005","volume":"48","author":"HF Ma","year":"2021","unstructured":"Ma HF, Shen Y, Luo D, Cai JF, Zou J, Guan JL. Analysis of 22 cases of Behcet\u2019s disease associated with trisomy 8 and literature review. Fudan Univ J Med Sci. 2021;48:457\u201362. https:\/\/doi.org\/10.3969\/j.issn.1672-8467.2021.04.005.","journal-title":"Fudan Univ J Med Sci"},{"key":"1035_CR58","doi-asserted-by":"publisher","first-page":"299","DOI":"10.12290\/xhyxzz.2022-0683","volume":"14","author":"WW Zhao","year":"2024","unstructured":"Zhao WW, Liu HM, Zhang TY, Yang SR, Sun L, Song HM. Clinical Features of Childhood Beh\u00e7et \u2019s Disease Like Trisomy 8: A Summary of 19 Cases. Med J Peking Union Med Coll Hosp. 2024;14:299\u2013305. https:\/\/doi.org\/10.12290\/xhyxzz.2022-0683.","journal-title":"Med J Peking Union Med Coll Hosp"},{"key":"1035_CR59","doi-asserted-by":"publisher","unstructured":"Wesner N, Drevon L, Guedon A, Fraison JB, Trad S, Kahn JE, et al. Inflammatory disorders associated with trisomy 8\u2010myelodysplastic syndromes: French retrospective case\u2010control study n.d. https:\/\/doi.org\/10.1111\/ejh.13174.","DOI":"10.1111\/ejh.13174"},{"key":"1035_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4078\/jrd.2021.28.2.107","volume":"28","author":"S Lee","year":"2021","unstructured":"Lee S, Choi WH, Kim J-S, Lee K-A, Jeon SR, Kim H-S. Trisomy 8 associated Beh\u00e7et\u2019s like disease. J Rheum Dis. 2021;28:107\u20139. https:\/\/doi.org\/10.4078\/jrd.2021.28.2.107.","journal-title":"J Rheum Dis"},{"key":"1035_CR61","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1182\/blood-2004-01-0103","volume":"104","author":"G Chen","year":"2004","unstructured":"Chen G, Zeng W, Miyazato A, Billings E, Maciejewski JP, Kajigaya S, et al. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood. 2004;104:4210\u20138. https:\/\/doi.org\/10.1182\/blood-2004-01-0103.","journal-title":"Blood"},{"key":"1035_CR62","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.hoc.2010.02.009","volume":"24","author":"EM Sloand","year":"2010","unstructured":"Sloand EM, Barrett AJ. Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success. Hematol Oncol Clin North Am. 2010;24:331\u201341. https:\/\/doi.org\/10.1016\/j.hoc.2010.02.009.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1035_CR63","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/RHU.0b013e3181776bde","volume":"14","author":"Y-C Lin","year":"2008","unstructured":"Lin Y-C, Liang T-H, Chang H-N, Lin J-S, Lin H-Y. Beh\u00e7et disease associated with myelodysplastic syndrome. JCR J Clin Rheumatol. 2008;14:169. https:\/\/doi.org\/10.1097\/RHU.0b013e3181776bde.","journal-title":"JCR J Clin Rheumatol"},{"key":"1035_CR64","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8535091","volume":"2018","author":"Y Shen","year":"2018","unstructured":"Shen Y, Ma H-F, Luo D, Cai J-F, Zou J, Guan J-L. High incidence of gastrointestinal ulceration and cytogenetic aberration of trisomy 8 as typical features of Beh\u00e7et\u2019s disease associated with myelodysplastic syndrome: a series of 16 consecutive Chinese patients from the Shanghai Beh\u00e7et\u2019s disease database and comparison with the literature. BioMed Res Int. 2018;2018:8535091. https:\/\/doi.org\/10.1155\/2018\/8535091.","journal-title":"BioMed Res Int"},{"key":"1035_CR65","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12032-017-1023-1","volume":"34","author":"AG de Matos","year":"2017","unstructured":"de Matos AG, Ribeiro Junior HL, de Paula BD, Okubo BM, de Sousa JC, Barbosa MC, et al. Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome. Med Oncol Northwood Lond Engl. 2017;34:168. https:\/\/doi.org\/10.1007\/s12032-017-1023-1.","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"1035_CR66","doi-asserted-by":"publisher","DOI":"10.18999\/nagjms.85.1.195","author":"N Takahashi","year":"2023","unstructured":"Takahashi N, Hanajiri R, Suzuki M, Anan C, Inagaki A, Kishida D, et al. <Editors\u2019Choice> Myelodysplastic syndrome with trisomy 8 presenting periodic fever and multiple MEFV gene variants outside exon 10: a case report. Nagoya J Med Sci. 2023. https:\/\/doi.org\/10.18999\/nagjms.85.1.195.","journal-title":"Nagoya J Med Sci"},{"key":"1035_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03878-y","volume":"20","author":"X Ding","year":"2025","unstructured":"Ding X, Yang J, Han X, Shen Y-F, Yang K, Shangguan Y, et al. Clinical features and novel pathogenic variants of patients with Beh\u00e7et\u2019s disease like trisomy 8. Orphanet J Rare Dis. 2025;20:340. https:\/\/doi.org\/10.1186\/s13023-025-03878-y.","journal-title":"Orphanet J Rare Dis"},{"key":"1035_CR68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13023-020-01411-x","volume":"15","author":"B Sun","year":"2020","unstructured":"Sun B, Chen Q, Wang Y, Liu D, Hou J, Wang W, et al. LIG4 syndrome: clinical and molecular characterization in a Chinese cohort. Orphanet J Rare Dis. 2020;15:131. https:\/\/doi.org\/10.1186\/s13023-020-01411-x.","journal-title":"Orphanet J Rare Dis"},{"key":"1035_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-5","volume":"2","author":"B Gruhn","year":"2007","unstructured":"Gruhn B, Seidel J, Zintl F, Varon R, T\u00f6nnies H, Neitzel H, et al. Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure. Orphanet J Rare Dis. 2007;2:5. https:\/\/doi.org\/10.1186\/1750-1172-2-5.","journal-title":"Orphanet J Rare Dis"},{"key":"1035_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10875-018-0587-7","volume":"39","author":"EZ Taskiran","year":"2019","unstructured":"Taskiran EZ, Sonmez HE, Kosukcu C, Tavukcuoglu E, Yazici G, Esendagli G, et al. A novel missense LIG4 mutation in a patient with a phenotype mimicking Beh\u00e7et\u2019s disease. J Clin Immunol. 2019;39:99\u2013105. https:\/\/doi.org\/10.1007\/s10875-018-0587-7.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1035_CR71","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2169\/internalmedicine.8227-21","volume":"61","author":"K Hisanaga","year":"2023","unstructured":"Hisanaga K. Neuro-Beh\u00e7et Disease, Neuro-Sweet Disease, and Spectrum Disorders. Intern med. 2023;61(4):447\u2013450. https:\/\/doi.org\/10.2169\/internalmedicine.8227-21","journal-title":"Intern med"},{"key":"1035_CR72","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1212\/01.WNL.0000161848.34159.B5","volume":"64","author":"K Hisanaga","year":"2005","unstructured":"Hisanaga K, Iwasaki Y, Itoyama Y, Neuro-Sweet Disease Study Group. Neuro-Sweet disease: clinical manifestations and criteria for diagnosis. Neurology. 2005;64:1756\u201361. https:\/\/doi.org\/10.1212\/01.WNL.0000161848.34159.B5.","journal-title":"Neurology"},{"key":"1035_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adh1641","volume":"17","author":"T Mukherjee","year":"2024","unstructured":"Mukherjee T, Kumar N, Chawla M, Philpott DJ, Basak S. The NF-\u03baB signaling system in the immunopathogenesis of inflammatory bowel disease. Sci Signal. 2024;17:eadh1641. https:\/\/doi.org\/10.1126\/scisignal.adh1641.","journal-title":"Sci Signal"},{"key":"1035_CR74","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jaci.2023.08.036","volume":"153","author":"K Baysac","year":"2024","unstructured":"Baysac K, Sun G, Nakano H, Schmitz EG, Cruz AC, Fisher C, et al. PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants. J Allergy Clin Immunol. 2024;153:230\u201342. https:\/\/doi.org\/10.1016\/j.jaci.2023.08.036.","journal-title":"J Allergy Clin Immunol"},{"key":"1035_CR75","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/ccr3.3934","volume":"9","author":"N Kutukculer","year":"2021","unstructured":"Kutukculer N, Topyildiz E, Berdeli A, Guven Bilgin B, Aykut A, Durmaz A, et al. Four diseases, PLAID, APLAID, FCAS3 and CVID and one gene (PHOSPHOLIPASE C, GAMMA-2; PLCG2): striking clinical phenotypic overlap and difference. Clin Case Rep. 2021;9:2023\u201331. https:\/\/doi.org\/10.1002\/ccr3.3934.","journal-title":"Clin Case Rep"},{"key":"1035_CR76","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12969-025-01131-1","volume":"23","author":"C Guan","year":"2025","unstructured":"Guan C, Wang W, Zhou Q, Sun J, Liu L, Liu L, et al. Mevalonate kinase deficiency: genetic and clinical characteristics of a Chinese pediatric cohort. Pediatr Rheumatol Online J. 2025;23:78. https:\/\/doi.org\/10.1186\/s12969-025-01131-1.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1035_CR77","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","volume":"172","author":"S Bekkering","year":"2018","unstructured":"Bekkering S, Arts RJW, Novakovic B, Kourtzelis I, van der Heijden CDCC, Li Y, et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell. 2018;172:135-146.e9. https:\/\/doi.org\/10.1016\/j.cell.2017.11.025.","journal-title":"Cell"},{"key":"1035_CR78","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10067-022-06384-9","volume":"42","author":"D Gezgin Y\u0131ld\u0131r\u0131m","year":"2023","unstructured":"Gezgin Y\u0131ld\u0131r\u0131m D, Y\u0131ld\u0131z Y\u0131ld\u0131r\u0131m \u00c7, Kara\u00e7ay\u0131r N, Esmeray \u015eenol P, Sunar Yayla EN, Bakkalo\u011flu SA. Recurrent macrophage activation syndrome due to hyperimmunoglobulin D syndrome: a case-based review. Clin Rheumatol. 2023;42:277\u201383. https:\/\/doi.org\/10.1007\/s10067-022-06384-9.","journal-title":"Clin Rheumatol"},{"key":"1035_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09164-7","volume":"7","author":"S Burillo-Sanz","year":"2017","unstructured":"Burillo-Sanz S, Montes-Cano M-A, Garc\u00eda-Lozano J-R, Ortiz-Fern\u00e1ndez L, Ortego-Centeno N, Garc\u00eda-Hern\u00e1ndez F-J, et al. Mutational profile of rare variants in inflammasome-related genes in Beh\u00e7et disease: a next generation sequencing approach. Sci Rep. 2017;7:8453. https:\/\/doi.org\/10.1038\/s41598-017-09164-7.","journal-title":"Sci Rep"},{"key":"1035_CR80","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000246388","volume":"192","author":"M Endoh","year":"2009","unstructured":"Endoh M, Yokozeki H, Maruyama R, Matsunaga T, Katayama I, Nishioka K. Incontinentia pigmenti and Beh\u00e7et\u2019s disease: a case of impaired neutrophil chemotaxis. Dermatology. 2009;192:285\u20137. https:\/\/doi.org\/10.1159\/000246388.","journal-title":"Dermatology"},{"key":"1035_CR81","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1399-0004.2010.01432.x","volume":"78","author":"H Takada","year":"2010","unstructured":"Takada H, Nomura A, Ishimura M, Ichiyama M, Ohga S, Hara T. NEMO mutation as a cause of familial occurrence of Beh\u00e7et\u2019s disease in female patients. Clin Genet. 2010;78:575\u20139. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01432.x.","journal-title":"Clin Genet"},{"key":"1035_CR82","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/ddg.12452","volume":"13","author":"C-K Juan","year":"2015","unstructured":"Juan C-K, Shen J-L, Yang C-S, Liu K-L, Chen Y-J. Flare-up of incontinentia pigmenti in association with Beh\u00e7et disease. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2015;13:154\u20136. https:\/\/doi.org\/10.1111\/ddg.12452.","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"key":"1035_CR83","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/814186","volume":"2011","author":"G M\u00e1rquez Balb\u00e1s","year":"2011","unstructured":"M\u00e1rquez Balb\u00e1s G, Gonz\u00e1lez-Ense\u00f1at MA, Vicente A, Creus-Vila L, Ant\u00f3n J, Umbert-Millet P. Incontinentia pigmenti and bipolar aphthosis: an unusual combination. ISRN Dermatol. 2011;2011:814186. https:\/\/doi.org\/10.5402\/2011\/814186.","journal-title":"ISRN Dermatol"},{"key":"1035_CR84","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.jaci.2016.05.030","volume":"138","author":"SE J\u00f8rgensen","year":"2016","unstructured":"J\u00f8rgensen SE, B\u00f8ttger P, Kofod-Olsen E, Holm M, M\u00f8rk N, \u00d8rntoft TF, et al. Ectodermal dysplasia with immunodeficiency caused by a branch-point mutation in IKBKG\/NEMO. J Allergy Clin Immunol. 2016;138:1706-1709.e4. https:\/\/doi.org\/10.1016\/j.jaci.2016.05.030.","journal-title":"J Allergy Clin Immunol"},{"key":"1035_CR85","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.molcel.2022.03.037","volume":"82","author":"M Du","year":"2022","unstructured":"Du M, Ea C-K, Fang Y, Chen ZJ. Liquid phase separation of NEMO induced by polyubiquitin chains activates NF-\u03baB. Mol Cell. 2022;82:2415-2426.e5. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.037.","journal-title":"Mol Cell"},{"key":"1035_CR86","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaut.2015.08.013","volume":"64","author":"M Takeuchi","year":"2015","unstructured":"Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Beh\u00e7et\u2019s disease: a comprehensive review. J Autoimmun. 2015;64:137\u201348. https:\/\/doi.org\/10.1016\/j.jaut.2015.08.013.","journal-title":"J Autoimmun"},{"key":"1035_CR87","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1002\/art.37708","volume":"64","author":"S Hou","year":"2012","unstructured":"Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, et al. Identification of a susceptibility locus in STAT4 for Beh\u00e7et's disease in Han Chinese in a genome-wide association study. Arthritis Rheum. 2012;64:4104\u201313. https:\/\/doi.org\/10.1002\/art.37708.","journal-title":"Arthritis Rheum."},{"key":"1035_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134632","volume":"10","author":"Z Jiang","year":"2015","unstructured":"Jiang Z, Hennein L, Tao Y, Tao L. Interleukin-23 receptor gene polymorphism may enhance expression of the IL-23 receptor, IL-17, TNF-\u03b1 and IL-6 in Behcet\u2019s disease. PLoS ONE. 2015;10:e0134632. https:\/\/doi.org\/10.1371\/journal.pone.0134632.","journal-title":"PLoS ONE"},{"key":"1035_CR89","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-089827","volume":"15","author":"BC Geertsema-Hoeve","year":"2025","unstructured":"Geertsema-Hoeve BC, van Laar JAM, Raaphorst J, Tas SW, Welsing PMJ, Goekoop RJ, et al. Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor Filgotinib in Beh\u00e7et\u2019s disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol. BMJ Open. 2025;15:e089827. https:\/\/doi.org\/10.1136\/bmjopen-2024-089827.","journal-title":"BMJ Open"},{"key":"1035_CR90","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/annrheumdis-2020-217307","volume":"79","author":"J Liu","year":"2020","unstructured":"Liu J, Hou Y, Sun L, Li C, Li L, Zhao Y, et al. A pilot study of Tofacitinib for refractory Beh\u00e7et\u2019s syndrome. Ann Rheum Dis. 2020;79:1517\u201320. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217307.","journal-title":"Ann Rheum Dis"},{"key":"1035_CR91","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.36849\/JDD.99181","volume":"24","author":"A Patel","year":"2025","unstructured":"Patel A, Guenin S, Amara S, Lebwohl M, Khattri S. Use of Upadacitinib in refractory Behcet\u2019s disease: case report and systematic literature review. J Drugs Dermatol JDD. 2025;24:e1-6.","journal-title":"J Drugs Dermatol JDD"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-026-01035-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-026-01035-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-026-01035-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:52:47Z","timestamp":1785772367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-026-01035-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1007\/s12519-026-01035-4","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have declared no conflict of interest. Authors Hong-Mei Song and Guo-Ying Huang are Editorial Board members of\n                      World Journal of Pediatrics\n                      . The paper was handled by the other Editors and has undergone a rigorous peer review process. Authors Hong-Mei Song and Guo-Ying Huang were not involved in the journal\u2019s review or decision-making for this manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}